The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Robert D ArbeitDaptomycin 98-01 and 99-01 Investigators

Abstract

Daptomycin is the first available agent from a new class of antibiotics, the cyclic lipopeptides, that has activity against a broad range of gram-positive pathogens, including organisms that are resistant to methicillin, vancomycin, and other currently available agents. Daptomycin (4 mg/kg intravenously [iv] every 24 h for 7-14 days) was compared with conventional antibiotics (penicillinase-resistant penicillins [4-12 g iv per day] or vancomycin [1 g iv every 12 h]) in 2 randomized, international trials involving 1092 patients with complicated skin and skin-structure infections. Among 902 clinically evaluable patients, clinical success rates were 83.4% and 84.2% for the daptomycin- and comparator-treated groups, respectively (95% confidence interval, -4.0 to 5.6). Among patients successfully treated with iv daptomycin, 63% required only 4-7 days of therapy, compared with 33% of comparator-treated patients (P<.0001). The frequency and distribution of adverse events were similar among both treatment groups. Overall, the safety and efficacy of daptomycin were comparable with conventional therapy.

References

Nov 11, 1991·Antimicrobial Agents and Chemotherapy·W E AlbornD A Preston
Dec 11, 1991·Antimicrobial Agents and Chemotherapy·N E AllenJ N Hobbs
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·P CanepariG Satta
Oct 8, 1999·The Journal of Antimicrobial Chemotherapy·R L Nichols
Oct 8, 1999·The Journal of Antimicrobial Chemotherapy·E RubinsteinG H Talbot
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·F B OlesonF P Tally
Nov 18, 2000·Antimicrobial Agents and Chemotherapy·D R SnydmanJ M Boyce
Apr 11, 2001·Emerging Infectious Diseases·F C TenoverM V Lancaster
May 17, 2001·Antimicrobial Agents and Chemotherapy·J A SilvermanT Li
May 17, 2001·Antimicrobial Agents and Chemotherapy·A L BarryS D Brown
Aug 2, 2001·The Journal of Antimicrobial Chemotherapy·A King, I Phillips
Jan 23, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kinan AttassiMarcus J Zervos
Feb 28, 2002·The Journal of Antimicrobial Chemotherapy·Peter C FuchsSteven D Brown
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·Eileen M Graffunder, Richard A Venezia
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John J EngemannKeith S Kaye
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Barry H DvorchikRobert D Arbeit
Jul 5, 2005·Expert Opinion on Investigational Drugs·F P TallyF B Oleson

❮ Previous
Next ❯

Citations

Jul 31, 2007·Advances in Therapy·Carl Fossaceca
Nov 15, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·B LuchtingA Beiras-Fernandez
Mar 14, 2012·European Journal of Clinical Pharmacology·Sepideh ElyasiAmirhooshang Mohammadpour
Sep 22, 2012·European Journal of Clinical Pharmacology·Sepideh ElyasiSimin Dashti-Khavidaki
Feb 11, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·W Behrens-BaumannT Ness
Nov 30, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G M Eliopoulos
Sep 28, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J R LentinoV L Yu
Sep 5, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Z A KanafaniH W Boucher
Dec 31, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S J van HalI B Gosbell
Sep 30, 2005·Journal of Industrial Microbiology & Biotechnology·Richard H BaltzStephen K Wrigley
Sep 21, 2007·Current Infectious Disease Reports·Gary E Stein
Aug 25, 2009·Current Infectious Disease Reports·Sandra Bliss Nelson
Jul 13, 2013·International Journal of Antimicrobial Agents·Ian M GouldMichael J Rybak
May 11, 2012·Enfermedades infecciosas y microbiología clínica·José Barberán, M Carmen Fariñas
Aug 3, 2007·International Journal of Antimicrobial Agents·A L CaseyT S J Elliott
Jul 22, 2010·The Journal of Antibiotics·Richard H Baltz
Aug 15, 2009·Nature Reviews. Microbiology·Henry F Chambers, Frank R Deleo
Nov 29, 2005·Natural Product Reports·Richard H BaltzStephen K Wrigley
Aug 18, 2006·The New England Journal of Medicine·M Lindsay Grayson
Aug 18, 2006·The New England Journal of Medicine·Vance G FowlerUNKNOWN S. aureus Endocarditis and Bacteremia Study Group
Mar 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher F Carpenter, Henry F Chambers
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary E Stein
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L Stevens
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stella PapadopoulosBrian S Murphy
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John F Mohr, Barbara E Murray
Sep 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott T Micek
Aug 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W Boucher, George Sakoulas
May 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George Sakoulas, Robert C Moellering
May 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin E Stryjewski, Henry F Chambers
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin E StryjewskiUNKNOWN Assessment of Telavancin in Complicated Skin and Skin-Structure Infections Study
Sep 16, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H KollefScott T Micek
Jan 1, 2005·Surgical Infections·David J Weber, William A Rutala
Oct 29, 2009·Surgical Infections·Addison K MayUNKNOWN Surgical Infection Society
May 13, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G Ralph Corey, Martin E Stryjewski
Sep 2, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Larry M Bush
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·P M Hawkey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The New England Journal of Medicine
Vance G FowlerS. aureus Endocarditis and Bacteremia Study Group
Antimicrobial Agents and Chemotherapy
John WeigeltLinezolid CSSTI Study Group
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Evelyn J Ellis-GrosseTigecycline 305 cSSSI Study Group
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Christopher F Carpenter, Henry F Chambers
© 2022 Meta ULC. All rights reserved